Skip to content

User Assessment of the NovaLife Two-Piece Flat Skin Barrier

User Assessment of the NovaLife Two-Piece Flat Skin Barrier - User Assessment of the NovaLife Two-Piece Flat Skin Barrier

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON40148
Enrollment
30
Registered
2014-02-24
Start date
2014-04-16
Completion date
Unknown
Last updated
2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

colostomy ileostomy

Interventions

Use of The DansacNovaLife Flat skin barriers GX+.

Sponsors

Dansac Limited/ Hollister Incorporated
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - is at least 18 years of age. - has an ileostomy or colostomy - is at least six weeks postoperative. - lives and cares for their stoma independently in the community. - currently uses a Dansac Nova or NovaLife 2-piece flat barrier - currently uses a drainable pouch. - is able to wear a 2-piece flat cut-to-fit 55 mm flange. - has a peristomal skin irritation score of 2 or less. - is willing to follow the protocol as demonstrated by signing the informed consent and who in the opinion of the Investigator is qualified to participate.

Exclusion criteria

Exclusion criteria: - has a fistula on or near the stoma. - has been involved in a study involving stoma care within the last 30 days. - is pregnant or lactating. - is undergoing chemotherapy, radiation or steroid therapy. - has an existing medical condition that would compromise their participation in the study.

Design outcomes

Primary

MeasureTime frame
The data will be compiled and reported descriptively. Analysis of the demographic profile and case report forms will be descriptive, with questions reported in tabular format. As this is not a comparative or statistically powered study, no hypothesis tests will be conducted.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)